SOURCE: Novo Nordisk A/S

October 01, 2009 07:24 ET

Novo Nordisk A/S: Treasury Stock

BAGSVAERD, DENMARK--(Marketwire - October 1, 2009) - Status regarding Novo Nordisk's holding of its own shares (30 September 2009)

In continuation of the company's announcement dated 6 August 2009 concerning a planned share repurchase programme, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 30 September 2009 owned 27,723,808 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 27,723,808 or 4.47% of the total share capital.

In the second quarter of 2009 a total of 8,592,500 B shares were repurchased, and 195,433 B shares were disposed of to employees in connection with employee incentive programmes.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs more than 28,500 employees in 81 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit

For further information please contact:

Media:                 Investors:

Outside North America: Outside North America:
Elin K Hansen          Mads Veggerby Lausten
Tel: (+45) 4442 3450   Tel: (+45) 4443 7919

                       Kasper Roseeuw Poulsen
                       Tel: (+45) 4442 4471

In North America:      In North America:
Sean Clements          Hans Rommer
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937

Company Announcement no 58 / 2009

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2009. All rights reserved.

Contact Information